KLRC1 and lymphoma: Therefore, it would be of interest to study expression of immune checkpoint receptors like PD1, TIGIT or NKG2A, exhaustion markers, and the functionality of lymphocytes and monocytes in patients with r/r lymphoma in comparison to patients in remission.